Close Menu

NEW YORK – Predictive Technology Group and Atrin Pharmaceuticals have partnered to develop molecular diagnostics to expedite improved selection of cancer patients who will benefit from treatment with DNA damage and response (DDR) inhibitors.

The partners plan to develop actionable predictive molecular and companion diagnostics and therapeutics for common disorders and related cancers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.